Monday, January 30, 2023
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
Daily Remedy
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    November 25, 2022
    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    November 25, 2022
    A conversation with Dr. Edwin Leap, physician writer and emergency medicine physician

    A conversation with Dr. Edwin Leap, writer and emergency medicine physician

    November 8, 2022
    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    October 31, 2022
    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    October 23, 2022
    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    October 23, 2022
  • Surveys

    Surveys

    Does inflation affect how you use your deductible?

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    December 12, 2022

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    November 25, 2022
    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    November 25, 2022
    A conversation with Dr. Edwin Leap, physician writer and emergency medicine physician

    A conversation with Dr. Edwin Leap, writer and emergency medicine physician

    November 8, 2022
    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    October 31, 2022
    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    October 23, 2022
    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    October 23, 2022
  • Surveys

    Surveys

    Does inflation affect how you use your deductible?

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    December 12, 2022

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Politics & Law

Pfizer’s Moral Hazard

Jay K Joshi by Jay K Joshi
August 8, 2021
in Politics & Law
0

In pre-pandemic America, the prospects of a pharmaceutical executive becoming a national hero would be slim at best. Yet during the pandemic it happened.

We learned the story of Pfizer’s CEO, a Greek Jewish immigrant, the son Holocaust survivors, who would go on to become the CEO of a company that would save the world – including Germany – by providing life saving vaccines.

The fairy tale story of redemption mirrored the company’s rise in public perception. Indeed few companies enjoyed as great a boost in popularity as Pfizer, according to the ComVix Reputation Index (CRI), a measure of overall corporate reputation.

But the rise in popularity was far more deliberate than we would initially imagine. Throughout the pandemic, Pfizer’s CEO crafted a carefully constructed rebranding program which emphasized the clinical studies and the scientists leading the studies. Dubbed a shift from “commerce to science”, the company introduced a new logo, swapping the blue pill shape with a double helix-inspired mark inspired by DNA’s double helix structure, alluding to the gene-based technology behind the company’s vaccine.

Then in early 2021, just as vaccine roll-out was set to hit the masses, Pfizer simultaneously unleashed a marketing campaign portraying the new perception of the company as a science-driven organization – a “smaller, science-based company” – shifting away from the traditional “house of brands” corporate strategy that most pharmaceutical companies used until this year.

It was also at this time that we began to see a lot more of Dr. Scott Gottlieb, former head of the FDA and current board member of Pfizer. No physician other than Dr. Anthony Fauci has seen more air time and television appearances than Dr. Gottlieb, who graced news outlets across the country discussing updates with the pandemic.

Over the course of his many news appearances, he developed a particular familiarity among the public, and with that familiarity came a certain level of trust.

Trust that propelled his and the company’s reputation until they both were seen as de facto saviors of the pandemic, leading America into its largest vaccination campaign ever, while working alongside the FDA and CDC to discuss the importance of getting vaccinated.

A partnership that validated for many the American model of healthcare, in which private companies work alongside public regulators to optimize the delicate balance of healthcare innovation, cost of care, and access to care.

A partnership that is currently a bit strained, testing its validity, ever since Pfizer announced it seeks FDA authorization for third dose of the COVID-19 vaccine, otherwise known as a booster dose.

An announcement government policy experts claim came unexpectedly, prompting a succinct rebuke in a rare joint statement.

“Americans who have been fully vaccinated do not need a booster shot at this time,” the CDC and FDA wrote in the statement.

The stunning back and forth was tempered over ensuing days, with Pfizer’s CEO issuing a private apology to Dr. Fauci and Dr. Gottlieb massaging news outlets like only he can, advocating that at least initiating the approval process for a booster dose is prudent, keenly noting that this is something Israel has already begun.

Israel has become the model nation, disseminating vaccines at a faster rate and to a greater percent of its population more than anywhere else in the world. But even Israel is advising caution around a booster dose.

All of which appear to be an opening gambit in an international game of diplomacy and public messaging, in which Pfizer attempts to convince the world that a booster dose is needed.

But Pfizer is still – irrespective of its new status as world savior – a private company, beholden to its shareholders. Who is to say whether Pfizer’s motives are more financial than clinical, influenced more by the bottom line than by the millions of at-risk patients across the world?

We simply do not know.

Suppose a clinical study comes out in the coming months demonstrating the value in receiving a booster dose, would people trust the data, and would they then decide to receive a third dose?

We struggle to understand the many risks these vaccines pose, even for complications that have been well-examined, such as heart inflammation.

And what we fail to understand, we most certainly do not trust.

So why should we trust Pfizer’s motives when we do not understand how to evaluate the value of a booster dose?

Pfizer has announced in the coming days that it will brief government officials regarding the science around booster doses for the COVID-19 vaccine. And government officials have repeatedly insisted that it will determine the need for booster doses according to the science.

But when has anything during the pandemic gone the way of science?

Seemingly every study or referenced data has been met with a mix of fervent support or adamant disbelief. There is nothing scientific about how the public has responded to the pandemic. And it is unlikely to change now.

Which makes Pfizer’s latest announcement all the more pressing, prompting a barrage of questions –

Are booster doses truly needed?

What is the scientific basis by which we determine the need for booster doses?

But most importantly –

Will people trust the data and the science behind it?

The most critical question in discerning whether people will eventually decide to receive the vaccine, reflecting not just if the public trusts the science, but also if it trusts Pfizer as a company.

Revealing the most fundamental question –

Is Pfizer motivated clinically or financially?

This is Pfizer’s moral hazard.

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

YouTube Video VVUxUDVQenU5RTFjUVFKNDY2ZlBmdFB3LmdVUm55WVpqRmNn This is a video about Elemental/Essential Frameworks of Healthcare Law

00:00 Elemental/Essential Frameworks of Healthcare Law
Load More... Subscribe

Expert vs. Lay Testimony

Visuals

NADAC (National Average Drug Acquisition Cost)

NADAC (National Average Drug Acquisition Cost)

by Jay K Joshi
January 29, 2023
0

We list the acquisition price of drugs that are covered under the Medicaid Drug Rebate Program - effectively, how much does the government pay for common drugs utilized by patients on Medicaid. Drugs listed are from A-CH.  

Read more

Twitter Updates

Tweets by DailyRemedy1

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

Popular

  • Letter to the Alabama Board of Medical Examiners

    Letter to the Alabama Board of Medical Examiners

    0 shares
    Share 0 Tweet 0
  • Prosecuting Doctors as Drug Dealers

    0 shares
    Share 0 Tweet 0
  • Why Our Prescribing were for Patients’ Best Interests

    0 shares
    Share 0 Tweet 0
  • My Respect for the Law

    0 shares
    Share 0 Tweet 0
  • Malicious Prosecution and Fabrication of Evidence

    0 shares
    Share 0 Tweet 0

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2023 Daily Remedy

No Result
View All Result
  • Home
  • Articles
    • Contrarian
    • Financial Markets
    • Innovations & Investing
    • Perspectives
    • Politics & Law
    • Trends
    • Uncertainty & Complexity
  • Podcasts
  • Surveys
    • Survey Results
  • About Us
  • Contact us
  • Support Us

© 2023 Daily Remedy

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do